MENU

Eureka projects

Patented drug formulations of a phthalocyanine photosensitiser based on microfludised lipids in a gel are being developed for photodynamic therapy of tumours together with non-coherent and coherent light sources suitable for the market.
Project ID: 
4511

Patented microcrystalized hydrophobic phtalocyanine liposomal drug form plus nayf4 (dopped by yb and er) nanoparticle drug form with matching lasers will be developed, converting 980 nm to 670 nm and enabling unlimited light penetration for infrared pdt curing tumors/metastases in any location.
Project ID: 
8020

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.